HIV Care and Treatment

For 340B-covered entities, core to the challenge of navigating a changing and uncertain policy landscape is the complexity of how multiple variables interact differently with each covered health care entity based on its unique makeup of services, funding, patient population, and payer mix. This toolkit aims to assist 340B covered entities in understanding their current areas of funding stability and where they are vulnerable, and to plan for the future.

Read More
HIV Care and Treatment
Navigating changes to the 340B drug pricing program: a toolkit for HIV-related healthcare entities in California

October 4, 2024

In light of proposed and actual changes in Federal and State policy that have the potential to affect the 340B program, we conducted a rapid response study, exploring the impact to facilities that serve people living with or at risk for HIV. As a companion to the Navigating 340B Toolkit, this Explainer takes a closer look at the answers to these three questions: 1. How does 340B work? 2. What is the relationship between 340B and HIV services? 3. What are the current factors impacting 340B revenue for HIV clinical and service organizations?

Read More
HIV Care and Treatment
Navigating 340B amidst policy changes: an explainer

October 4, 2024

Climate disasters are becoming more frequent and intense in California, with direct and indirect impacts on public health, including HIV care services. As client needs surge during and after climate disasters, service gaps are widening due to workforce migration from areas heavily impacted by climate change. This brief report highlights key findings from a study that our center recently published in PLOS Climate on the experiences of health care providers in regions heavily impacted by climate change.

Read More
HIV Care and Treatment
Impact of Climate-Related Events on the HIV Care Workforce in California

March 21, 2024

Infographic Phase II: Assessing Smoking Cessation Services in Central and Northern California HIV Safety Nets January 17, 2024 This publication is phase II of an audit or “secret shopper” study that sought to characterize current access to smoking cessation services in Central and Northern California HIV safety nets and to identify potential strategies for increasing […]

Read More
HIV Care and Treatment
Phase II: Assessing Smoking Cessation Services in Central and Northern California HIV Safety Nets

January 17, 2024

Paper “Am I going to have to run to get out of this place?” A qualitative study exploring HIV clinical and service provider experiences from California regions heavily impacted by climate disaster October 25, 2023 In California, disaster events and extreme conditions caused by climate change are becoming more frequent and intense, impacting many regions […]

Read More
HIV Care and Treatment
“Am I going to have to run to get out of this place?” A qualitative study exploring HIV clinical and service provider experiences from California regions heavily impacted by climate disaster

October 25, 2023

Infographic Zero-Cost Preventative Care for Californians & Extended Coverage for STI Screenings September 10, 2023 Employer coverage for PrEP is at risk—proposed legislation in California seeks to preserve and extend coverage for PrEP and other preventative care. Learn more about the Texas case Braidwood Management v. Becerra and what California Assembly Bill 1645 will do to address […]

Read More
HIV Care and Treatment
Zero-Cost Preventative Care for Californians & Extended Coverage for STI Screenings

September 10, 2023

Policy Brief Are California pharmacists ready to provide long-acting injectable pre- exposure prophylaxis (PrEP) for HIV prevention? July 31, 2023 A new CHPRC analysis finds strong potential to increase access to long-acting injectable forms of HIV prevention in California pharmacies. Pharmacists surveyed were highly supportive of pharmacy-based PrEP provision under Senate Bill 159, and more […]

Read More
HIV Care and Treatment
Are California pharmacists ready to provide long-acting injectable pre- exposure prophylaxis (PrEP) for HIV prevention?

July 31, 2023